Decision

LYTIX.OL - Lytix Biopharma AS

BUY

Buy looks strongest now

Score, ranking, and quality support a positive call right now.

10.80 NOK

+0.20 (+1.89%)

Last updated: 2026-03-18

SCORE 6.47 | N/A Rank #2 | Healthcare

Portfolio Not in portfolio Test it against your portfolio before adding risk.

Dividend / outlook Dividend is secondary Focus on signal and quality rather than dividend here. 12 month outlook: -21.00%

Back to market Log in

Signal drivers

Start with score, grade, and the latest model updates.

Period

Short

Medium

Long

Intraday

0.23

0.68

0.32

EOD

4.90

6.47

6.25

1min updated: 2025-05-12 14:20:20 | EOD updated: 2026-03-18

Expected path

Trend-based estimate for direction, upside, and downside.

3 months 13.89 NOK +28.58% 95% CI: 7.70 - 25.05 NOK

12 months 8.53 NOK -21.00% 95% CI: 2.62 - 27.77 NOK

18 months 14.20 NOK +31.50% 95% CI: 3.35 - 60.27 NOK

Dividend case

No clear dividend history

Latest dividend N/A

Last payout date N/A

Dividend score N/A

DGPS N/A

DSS N/A

Yield this year N/A

Yield last year N/A

Total dividend years 0

Consecutive dividend years 0

Key facts

Market cap 678 599 996

Beta -0.46

Grade updated N/A

EOD updated 2026-03-18

LYTIX.OL - Lytix Biopharma AS

Signal drivers

Expected path

Dividend case

Key facts

Similar stocks in sector